chemotherapy or HIV. Therefore, flight attendants and others say that airplane cabin air should be held to higher standards than workplaces.
Pressure from passengers may be a major contributing factor in encouraging airlines to increase fresh air. In the August issue of Consumer Reports, airlines were ranked according to levels of carbon dioxide in airplane cabins and criticized for the low amounts of fresh air. Consumer Reports recommended that passengers choose airlines according to the amounts of fresh air they circulate. They also recommended that the FAA set a comfort standard of 1,000 ppm. with regulation of cell processes or metabolic pathways. Second, the transduced cells may contain a selective growth advantage, enabling their progeny to predominate in the host. When such cells are introduced into a patient during gene therapy, they represent a population carrying a "first hit" insertional event that may put the patient at increased risk for additional mutational events leading potentially to tumor formation. Third, retroviral vector preparations may be contaminated by virions containing packaging cell RNA. In theory, this RNA could be reverse-transcribed, integrate in the genome of the recipient cells, and express a product that could disrupt normal cell functioning.
The risk posed by insertional mutagenesis is a particular concern for extending gene therapy to the treatment of conditions such as diabetes or hemophilia where substantial numbers of people would be candidates for the therapy and might be treated early in their lives. A population of cells carrying a first hit insertional event would put such people at an increased risk throughout the remainder of their lives.
As gene therapies are expanded for the treatment of more diseases, the sheer numbers of people involved makes it more likely that even a relatively infrequent event may result in an unacceptably high risk. Irwin and his colleagues at the NIEHS are developing studies to attempt to evaluate the extent of this risk. In these studies, researchers will expose mice and rats to retroviral vectors in a number of ways. These vectors contain marker genes which allow the researchers to determine the most effective method of integration of the vector into the new cell genome. The animals are allowed to live out their life spans, and researchers then examine them to see if they developed tumors, and if so, if the tumors contained DNA from the retroviral vector. The information from these studies will be used to estimate gene therapy's risk and may help regulators evaluate the safety of cutting edge technology.
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